Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03819712

Identification of Predictive Blood Biomarkers of Recurrent Urinary Tract Infections

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
109 (actual)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
Female
Age
18 Years – 28 Years
Healthy volunteers
Accepted

Summary

Urinary tract infections affect more than 130 million people worldwide each year. Almost 50% of women will have at least one urinary tract infection during their lifetime, usually cystitis. Half of them will have recurrent cystitis. Antibiotics are the first-line treatment for cystitis, but their effectiveness is decreasing due to the rapid spread of multi-resistant uro-pathogenic bacteria. The objective of this study is to identify blood biomarkers associated with a high risk of recurrent cystitis. Immune system cells, and more specifically innate immunity cells, play a key role in controlling urinary tract infections. In addition, clinical studies have shown that there is a high inter-individual variability in the ability of innate immune cells to respond to different stimuli. We therefore hypothesized that there was an association between the risk of recurrent cystitis and a deficiency of certain immune cell types in producing certain pro-inflammatory cytokines, including TNF-α, in response to one or more bacterial stimuli, particularly flagellin.

Conditions

Interventions

TypeNameDescription
PROCEDURECollection of blood samples23 mL of blood will be collected during the inclusion visit
OTHERCollection of fecal samplesFecal sample self-collected after the inclusion visit
OTHERCollection of urine samples10 mL of urine will be collected during the inclusion visit
OTHERCollection of vaginal swapsSample of vaginal microbiota collected during the inclusion visit

Timeline

Start date
2019-06-03
Primary completion
2023-12-03
Completion
2025-12-31
First posted
2019-01-28
Last updated
2025-12-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03819712. Inclusion in this directory is not an endorsement.